YINGSHENGBIOLOGY

Shandong YingSheng Biotechnology Co., Ltd. (referred to as YINGSHENGBIOLOGY) was established in 2009, with its R&D and production base located in the Jinan High-tech Development Zone. Since its inception, it has focused on the independent research, production, and sales of in vitro diagnostic reagents and medical equipment. It has built genetic testing and mass spectrometry platforms around genomics and mass spectrometry, covering areas such as birth defect screening, disease prevention, and human health services. At the same time, YINGSHENGBIOLOGY always prioritizes clinical needs, dedicating itself to creating a one-stop mass spectrometry solution that fully serves and resolves customer issues. Listed as a key enterprise in Shandong Province's "13th Five-Year Plan" for scientific and technological innovation, specifically within the biomedical engineering industry cluster. The company’s product line includes self-developed innovative series of deafness gene detection kits, newborn screening reagents for 45 inherited metabolic diseases, vitamin assay reagents for 14 items, HLA-B27 detection kits, an intelligent mass spectrometry automation platform, ultra-high-performance liquid chromatography-tandem mass spectrometry systems, and supporting software. Both products and software are domestically first-of-their-kind and internationally leading.